Article: Growth Hormone Therapy Affects Some Adrenal Gland Hormones.(Brief Article)

Article: Serono's Serostim(R) Improves Lean Body Mass and Physical ...
PR Newswire;  March 31, 2004 ;     700+ words ... ... performance in patients with HIV- associated wasting, according to study data ... Antiretroviral Therapy"). (1) HIV-associated wasting is a chronically debilitating ... human growth hormone in HIV-associated wasting, confirmed the efficacy ...

Article: Serostim improves lean body mass in HIV-associated ...
Drug Week;  April 30, 2004 ;     700+ words ... ... performance in patients with HIV- associated wasting, according to study data ... human growth hormone in HIV-associated wasting, confirmed the efficacy ... treated 757 patients with HIV-associated wasting at U.S., European ...

Article: EMD Serono, Inc. Launches Reimbursement Initiative to Increase ...
AIDS Weekly;  October 27, 2008 ;     700+ words ... ... patients diagnosed with HIV-associated wasting who are prescribed Serostim ... in financial support to HIV-associated wasting patients. The Company ... treatment regimens for HIV-associated wasting and the potential cost ...

Article: Drug receives FDA approval to treat HIV-associated ...
Health & Medicine Week;  September 29, 2003 ;     700+ words ... ... benefits of highly active antiretroviral therapy." HIV-associated wasting is a chronically debilitating and potentially ... wasting. The study treated 757 patients with HIV-associated wasting at U.S., European, and other international ...

Article: Current treatment trends involving HIV-associated ...
Formulary;  August 1, 2002 ;     700+ words ...Diagnosis of Wasting Obviously the first step in diagnosis is the history and physical examination during which we note any recent weight loss. Some type of sequential analysis of body cell mass needs to be incorporated into the exam. This can be very easily accomplished using bioelectric impedance

Article: US FDA AUTHORIZES CELGENE TO PROVIDE EXPANDED ACCESS TO SYNOVIR ...
PR Newswire;  August 28, 1995 ;     700+ words ... ... loss condition. The FDA's action authorizes an open-label compassionate use protocol for patients with HIV-Associated Wasting Syndrome. The protocol is complementary to Celgene's placebo controlled multi-center HIV wasting trial with ...

Article: Treatment With Serostim Decreased Visceral Adipose Tissue in ...
PR Newswire;  March 1, 2004 ;     700+ words ... ... Food and Drug Administration for the treatment of HIV-associated wasting or cachexia. The recommended dose is 0.1 mg ... e., glucose intolerance. In patients with HIV-associated wasting, Serostim(R) has a generally manageable side ...